Meltzer HY, Burnett S, Bastani B, et al. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Comm Psychiatry 1990; 41: 892-897.
Awad AG, Voruganti LNP, Heslegrave RJ. Measurement of quality of life in schizophrenia. PharmacoEconomics (in press)
Lancet. Quality of life and clinical trials. Lancet 1995; 346: 1-2.
Awad AG. Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Comm Psychiatry 1992; 43: 262-265.
Awad AG. Methodological and design issues in clinical trials of new neuroleptics: an overview. Br J Psychiatry 1993; 163(Suppl. 22): 51-57.
Awad A. Quality of life issues in medicated schizophrenics: therapeutic and research implications. In: Contemporary Issues in the Treatment of Schizophrenia. Shariqui CL, Nasrallah H, eds. Washington DC: American Psychiatric Press, 1995.
Lehman A, Ward N, Linn L. Chronic mental patients: the quality of life issue. Am J Psychiatry 1982; 139: 1271-1276.
Lehman A. The well-being of chronic mental patients: assessing their quality of life. Arch Gen Psychitatry 1983; 40: 369-373.
Lehman A. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval Prog Plan 1983; 6: 143-151.
Lehman A, Possidente S, Hawker F. The quality of life of chronic patients in a state hospital and in community residences. Hosp Comm Psychiatry 1986; 37: 901-907.
Sullivan G, Wells K, Leake B. Quality of life of seriously mentally ill persons in Mississippi. Hosp Comm Psychiatry 1991; 42: 752-754.
Levitt AJ, Hogan TP, Bucosky CM. Quality of life in chronically mentally ill patients in day treatment. Psychological Med 1990; 20: 703-710.
Corten P, Mercier C, Pelc I. "subjective quality of life’: clinical model for assessment of rehabilitation treatment in psychiatry. Soc Psychiatry Psychiatr Epidemiol 1994; 29: 178-183.
Gill T, Feinstein A. A critical appraisal of the quality of life measurements. JAMA 1994; 272: 619-626.
Kay S, Fiszbein A, Opler L. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schiz Bull 1987; 13: 261.
Fleishhacker WW, Bergmann KJ, Perovich R, et al. The Hillside Akathisia Scale: A new rating instrument for neuroleptic induced akathisia. Psychopharm Bull 1989; 25: 222-226.
Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised 1976. Washington DC: US Department of Health, Education and Welfare, 1976.
Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Med 1983; 13: 177-183.
Hogan T, Awad A. Subjective response to neuroleptics and outcome in schizophrenia: A re-examination comparing two measures. Psychological Med 1992; 22: 347-352.
Wykes T, Stuart E. The measurement of social behaviour in psychiatric patients: an assessment of the reliability and validity of the SBS schedule. Br J Psychiatry 1986; 148: 1-11.
Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766-771.
Gurin G, Verhoff J, Feld S. Americans View Their Mental Health. New York, NY: Russel Sage Foundation, 1960.
Bachrach L. Deinstitutionalization: An Analytic Review and Sociological Perspective. Rockville, MD: National Institute of Mental Health, 1976.
Strauss JS. Subjective experiences of schizophrenia: towards a new dynamic psychiatry. Schiz Bull 1987 15: 178-179.
Singh MM, Kay SR. Dysphoric response to neuroleptic treatment in schizophrenia: its relationship to autonomic arousal and prognosis. Biolog Psychiatry 1979; 14: 277-294.
Van Putten T, May PRA, Marder SR. Subjective response to thiothixene and chlorpromazine. Psychopharma Bull 1980: 16-18.
Awad AG, Hogan TP. Early treatment events and prediction of response to neuroleptics in schizophrenia. Prog Neuropsychopharma Biolog Psychiatry 1985; 9: 585-588.
VanPutten T, May PRA, Marder SR, et al. Subjective response to antipsychotic drugs. Arch Gen Psychiatry 1981; 38: 187-190.
Diamond R. Drugs and quality of life: The patient's point of view. J Clin Psychiatry
Awad AG. Subjective response to neuroleptics in schizophrenia. Schiz Bull 1993; 19: 609-617.
Awad AG, Hogan TP, Voruganti LNP, Heslegrave RJ. Patients' experiences on antipsychotic medications: implications for outcome and quality of life. Int Clin Psyhcopharm 1995; 10(Suppl 3): 123-132
Brekke JS, Levin S, Wolkon GH et al. Psychosocial functioning and subjective experience in schizophrenia. Schiz Bull 1993; 19: 599-608.
Romney DM. Psychosocial functioning and subjective experience in schizophrenia: A reanalysis. Schiz Bull 1995; 21: 405-410.